Allen Ebens

Director/Board Member at PRESCIENT THERAPEUTICS LIMITED

Health Technology

Consumer Services

Profile

Dr. Allen Ebens is a Director & Chief Scientific Officer at Virsti Therapeutics, Inc. and an Executive Vice President-Research at Vera Therapeutics, Inc. He is on the Board of Directors at Prescient Therapeutics Ltd. and Virsti Therapeutics, Inc. Dr. Ebens was previously employed as a Senior Director-Immune Oncology by NGM Biopharmaceuticals, Inc. He received his doctorate degree from the University of California, Los Angeles.

Allen Ebens active positions

Companies	Position	Start
PRESCIENT THERAPEUTICS LIMITED	Director/Board Member	2020-05-31
VERA THERAPEUTICS, INC.	Corporate Officer/Principal	2024-10-31
Virsti Therapeutics, Inc.	Chief Tech/Sci/R&D Officer	-

All active positions of Allen Ebens

Former positions of Allen Ebens

Companies	Position	End
NGM BIOPHARMACEUTICALS, INC.	Corporate Officer/Principal	2018-08-31

See the detail of Allen Ebens's experience

Education of Allen Ebens

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Allen Ebens's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
NGM Biopharmaceuticals, Inc. NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines	Health Technology
Prescient Therapeutics Ltd. Prescient Therapeutics Ltd. BiotechnologyHealth Technology Operates as a a clinical stage oncology company	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vera Therapeutics, Inc. Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases	Health Technology
Virsti Therapeutics, Inc.